RPRX Related Earnings
-
Repros Therapeutics, Inc. (RPRX) Posts Q1 Loss of 41c/Share
-
Repros Therapeutics, Inc. (RPRX) Posts Wider than Expected Q4 Loss
-
Repros Therapeutics, Inc. (RPRX) Posts Q3 Loss of 30c/Share
-
Repros Therapeutics, Inc. (RPRX) Posts Wider than Expected Q2 Loss of 21c/Share
-
Repros Therapeutics, Inc. (RPRX) Tops Q4 EPS by 6c
-
Repros Therapeutics, Inc. (RPRX) Posts Narrower than Expected Q3 Loss
-
Repros Therapeutics, Inc. (RPRX) Reports Q2 Loss of $0.30
-
Repros Therapeutics, Inc. (RPRX) Posts Q1 EPS Loss of $0.20
-
Repros Therapeutics (RPRX) Posts Narrower-than-Expected Q4 Loss
-
Repros Therapeutics (RPRX) Reports Q2 Loss of 4c
-
Repros Therapeutics (RPRX) Reports Wider-Than-Expected Q2 Loss of $0.59; Receives Notices from FDA, Nasdaq
-
Repros Therapeutics (RPRX) Reports Mixed Q4 Results
Back to RPRX Stock Lookup
